 MiMedx Group, Inc. NASDAQ:MDXG Q3 2022 Earnings Conference Call November 2, 2022 5:00 PM ET Company Participants Matt Notarianni Head-Investor Relations Todd Newton Interim Chief Executive Officer Pete Carlson Chief Financial Officer Rohit Kashyap President-Wound and Surgical Robert Stein President-Regenerative Medicine Conference Call Participants Anthony Petrone Mizuho Group RK H.C. Wainwright Carl Byrnes Northland Capital John Vandermosten Zacks Operator Good afternoon and thank you for standing by. 